Skip to content

Pneumococcal 20-valent Conjugate Vaccine

Published: August 9, 2026Updated: August 9, 2026

Prevnar 20 is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria. It provides immunization against 20 different serotypes of this bacterium, which can cause serious conditions like pneumonia, meningitis, and bloodstream infections. This vaccine is approved for use in adults and certain pediatric populations.

Quick summary

Prevnar 20 is a pneumococcal conjugate vaccine that protects against 20 strains of bacteria causing pneumonia, meningitis, and other serious infections.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 9, 2026Editorial policy

Key facts at a glance

RxNorm
2566310
Generic
Prevnar 20
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Prevnar 20 is used to prevent pneumococcal diseases including pneumonia, meningitis, bloodstream infections (bacteremia), and ear infections (otitis media) caused by Streptococcus pneumoniae. It is approved for active immunization in adults 18 years and older, and in infants and children from 6 weeks through 17 years of age.

Prevnar 20 is a conjugate vaccine that contains purified capsular polysaccharides from 20 pneumococcal serotypes, each conjugated to a carrier protein. This formulation stimulates the immune system to produce antibodies against the pneumococcal bacteria without causing disease. Vaccination induces protective immunity against the covered serotypes.

Prevnar 20 is administered as an intramuscular injection. Common side effects may include injection site pain, fatigue, headache, and muscle pain. Individuals with severe allergic reactions to any component of the vaccine or to diphtheria toxoid should not receive this vaccine. Vaccination schedules vary by age and risk factors, and should be determined by a healthcare provider.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy